A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: Results from the EuroSIDA study

HIV Clinical Trials

Volumn 12, Issue 2, 2011, Pages 109-117

  Kowalska, Justyna D ^a   Mocroft, Amanda ^b   Ledergerber, Bruno ^c   Florence, Eric ^d   Ristola, Matti ^e   Begovac, Josip ^f   Sambatakou, Helen ^g   Pedersen, Court ^h   Lundgren, Jens D ^a,i   Kirk, Ole ^a,i  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f Croatia   (Croatia)

^g UNIVERSITY OF ATHENS   (Greece)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ Rigshospitalet   (Denmark)

Author keywords

AIDS; cause of death; CoDe project; HIV; mortality; non AIDS event

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ARTICLE; CAUSE OF DEATH; COMPUTER AIDED DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STANDARDIZATION; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALGORITHMS; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; HIV-1; HUMANS; PROSPECTIVE STUDIES;

EID: 79955072492     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1202-109     Document Type: Article

References (23)

1. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med.2005;6(2):99-106. (Pubitemid 40425973)
2. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol.2009;38(6):1624-1633.
3. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007;146(2):87-95. (Pubitemid 351640011)
4. Jaggy C, von OJ, Ledergerber B, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet. 2003;362(9387):877-878. (Pubitemid 37130098)
5. Martinez E, Milinkovic A, Buira E, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med. 2007;8(4):251-258. (Pubitemid 46695372)
6. The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50(10):1387-1396.
7. Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590-598.
8. Rosenthal E, Salmon-Ceron D, Lewden C, et al.Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19). HIV Med.2009;10(5):282-289.
9. Monforte A, Abrams D, Pradier C, et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS. 2008;22(16):2143-2153.
10. Marin B, Thiebaut R, Bucher HC, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23(13):1743-1753.
11. Zwahlen M, Lundgren JD. Commentary: death in the era of potent antiretroviral therapy: shifting causes, new challenges.Int J Epidemiol. 2005;34(1):130-131. (Pubitemid 40347382)
12. Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. 1999;13(15):2075-2082. (Pubitemid 29509584)
13. Coding Causes of Death in HIV protocol version 1.0. CoDe Web site. February 2005. http://www.cphiv.dk/Portals/-default/pdf-folder/code-protocol- ver-1.0.pdf. Accessed February 2005.
14. Kowalska JD, Friis-Moller N, Kirk O, et al. The Coding Causes of Death in HIV (CoDe) Project - initial results and evaluation of methodology. The CoDe Working Group and the D:A:D Study Group. Epidemiology. In press.
15. The HIV-TB Project. The HIV-TB Project Web site. 2009.http://www.cphiv. dk/HIVTB/tabid/284/Default.aspx.Accessed February 2009.
16. Podlekareva D, Bannister W, Mocroft A, et al. The Euro-SIDA study: regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIVinfected patients across Europe--a review of published results. Cent Eur J Public Health. 2008;16(3):99-105.
17. Grabar S, Lanoy E, Allavena C, et al. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med. 2008;9(4):246-256. (Pubitemid 351467799)
18. Mocroft AJ, Lundgren JD, d'Armino MA, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol.1997;26(2):400-407. (Pubitemid 27190313)
19. Mocroft A, Youle M, Morcinek J, et al. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. BMJ. 1997;314(7078):409-413. (Pubitemid 27067802)
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. (Pubitemid 8054849)
21. Aung E, Rao C, Walker S. Teaching cause-of-death certification: lessons from international experience. Postgrad Med J. 2010;86(1013):143-152.
22. Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med.2009;361(16):1548-1559.
23. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet.2005;366(9483):378-384 (Pubitemid 41073955)